Making the subtle noticeable: Transforming veterinary care with technologyJune 2, 2020Clinicians love a good challenge, even the really tough ones. Yet, frustration arises when we cannot seem to make any headway in improving a pet’s condition.
SPONSORED CONTENTCanine CHF Management approved by the FDAStudies have demonstrated increased survival time for dogs with certain types of CHF. + Learn More
13 open-wound management mistakes to avoidJune 2, 2020If you follow these 13 basic principles, healing will be faster, costs will be lower, and both your client and your patient will be happier.
Another zebra diagnosis: Granulomatosis with polyangiitisJune 2, 2020Wegener’s granulomatosis may appear to be an aggressive cancerous lesion, and if mistakenly identified as a malignant process, improper treatment may ensue.
Beyond private practice: Serving in the public domainJune 2, 2020While it is true the majority of veterinarians are in private clinical practice, approximately 25 to 30 percent of veterinarians serve in a public practice capacity.
AI in veterinary medicine: From finding disease to predicting itJune 2, 2020What if we could find disease before it begins? While it may sound like science fiction, it’s currently underway in both human and animal health by coupling advanced computing power with artificial intelligence (AI).
Managing canine osteoarthritis in all stages and agesJune 2, 2020Evidence shows the most predictably successful method to managing OA in dogs is a proactive approach emphasizing prevention.
Can old vaccines reveal new secrets?June 2, 2020The COVID-19 pandemic has brought the return of a period many of us have never experienced—a time before vaccines, when medicine had little power to stop the spread of infectious diseases.
A closer look at popular pet food myths… and why they are just thatJune 2, 2020The perfect food for dogs and cats is unknown and probably doesn’t exist, and the pressure to find this diet can easily lead to extreme and unhealthy choices.
VPN Plus+ ExclusiveCBD or CBD and THC combined?May 29, 2020While cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) are both phytocannabinoids derived from cannabis plants, differences in their chemical structures allow each to interact with unique receptors, resulting in distinct molecular targets and physiological effects. Namely, THC shows high affinity toward CB1 receptors, which are present in central and peripheral neurons, resulting in the euphoric effect commonly attributed to cannabis intoxication. In contrast, CBD does not bind CB1 at relevant concentrations and is nonintoxicating. Instead, CBD interacts, to various degrees, with other receptors (agonism at TRPV1 and 5-HT1A, antagonism at TNFα, GPR55, and GPR18), which may be relevant for its suggested therapeutic effects. Practical considerations Recently, CBD- and THC-containing products for people and pets have become more widely available, especially in jurisdictions that have passed legislation allowing the sale of such items intended for human use. Evolving regulatory frameworks and social perceptions have also renewed interest in the potential therapeutic properties of cannabinoids for animals. Importantly, there are no authorized veterinary drugs containing cannabinoids in the U.S., and any state laws permitting the use of medical cannabis do not apply to use in animals. Increasingly, the veterinary profession is being asked to weigh in on the potential roles of CBD and …
Support shelters get $400k shot in the armMay 27, 2020Animal shelters impacted by COVID-19 might soon feel relief, thanks to a joint venture from Hill’s Pet Nutrition and the Association for Animal Welfare Advancement.
